Sequencing Abiraterone and Enzalutamide in mCRPC
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02125357 |
Recruitment Status :
Completed
First Posted : April 29, 2014
Last Update Posted : August 7, 2020
|
Sponsor:
British Columbia Cancer Agency
Information provided by (Responsible Party):
British Columbia Cancer Agency
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | February 4, 2020 |
Actual Study Completion Date : | February 4, 2020 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):